We are live on ! Find out more
SER icon

Serina Therapeutics
SER

51 hedge funds and large institutions have $11.9M invested in Serina Therapeutics in 2019 Q4 according to their latest regulatory filings, with 6 funds opening new positions, 15 increasing their positions, 11 reducing their positions, and 11 closing their positions.

New
Increased
Maintained
Reduced
Closed

36% more repeat investments, than reductions

Existing positions increased: 15 | Existing positions reduced: 11

0% more funds holding in top 10

Funds holding in top 10: 2 → 2 (0)

0.01% less ownership

Funds ownership: 0.5% → 0.49% (-0.01%)

9% less funds holding

Funds holding: 56 → 51 (-5)

9% less capital invested

Capital invested by funds: $13.1M → $11.9M (-$1.22M)

45% less first-time investments, than exits

New positions opened: 6 | Existing positions closed: 11

Holders
51
Holders Change
-5
Holders Change %
-8.93%
% of All Funds
1%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.04%
New
6
Increased
15
Reduced
11
Closed
11
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
JP Morgan Chase
JP Morgan Chase
New York
+$32.2K
2
Morgan Stanley
Morgan Stanley
New York
+$29.2K
3
VOYA Investment Management
VOYA Investment Management
Georgia
+$27.7K
4
UBS Group
UBS Group
Switzerland
+$19K
5
State Street
State Street
Massachusetts
+$17.3K

Top Sellers

Rank Fund Capital Flow
1
DC
Defender Capital
North Carolina
-$103K
2
PAM
Panagora Asset Management
Massachusetts
-$96.8K
3
PCM
Price Capital Management
Louisiana
-$47K
4
Wells Fargo
Wells Fargo
California
-$39.6K
5
Squarepoint
Squarepoint
New York
-$38K
Name Holding Trade Value Shares
Change 		Change in
Stake
Bank of America
26
Bank of America
North Carolina
$14K -$2.32K -43 -17%
New York State Common Retirement Fund
27
New York State Common Retirement Fund
New York
$13K – – –
Deutsche Bank
28
Deutsche Bank
Germany
$12K +$2.21K +41 +24%
Wells Fargo
29
Wells Fargo
California
$10K -$39.6K -733 -81%
Legal & General Group
30
Legal & General Group
United Kingdom
$8K +$1.35K +25 +25%
Citigroup
31
Citigroup
New York
$8K +$4.27K +79 +172%
Bank of Montreal
32
Bank of Montreal
Ontario, Canada
$6K +$1.24K +23 +35%
BNP Paribas Financial Markets
33
BNP Paribas Financial Markets
France
$5.26K +$1.03K +19 +30%
S
34
SignatureFD
Georgia
$5K +$3.83K +71 New
TRCT
35
Tower Research Capital (TRC)
New York
$3K +$648 +12 +39%
RAM
36
Riggs Asset Management
Pennsylvania
$2K – – –
MAM
37
Meeder Asset Management
Ohio
$2K +$702 +13 +72%
RE
38
RBC Europe
United Kingdom
$1.04K – – –
AIP
39
Ameritas Investment Partners
Nebraska
$1K – – –
PP
40
Pacifica Partners
Canada
$1K +$432 +8 New
SHWM
41
Silicon Hills Wealth Management
Texas
$1 – – –
PCM
42
Price Capital Management
Louisiana
– -$47K -636 Closed
Squarepoint
43
Squarepoint
New York
– -$38K -554 Closed
HF
44
HRT Financial
New York
– -$26K -387 Closed
SC
45
Scotia Capital
Ontario, Canada
– -$26K -380 Closed
Susquehanna International Group
46
Susquehanna International Group
Pennsylvania
– -$21K -302 Closed
Victory Capital Management
47
Victory Capital Management
Texas
– -$7K -107 Closed
BDS
48
Banco de Sabadell
Florida
– -$4K -57 Closed
Fidelity Investments
49
Fidelity Investments
Massachusetts
– -$2K -28 Closed
Royal Bank of Canada
50
Royal Bank of Canada
Ontario, Canada
– -$1.08K -20 -91%
1
2
3

SER Hedge Fund Activity: Q4 2019 in Review

51 of the 5,075 institutional investors tracked by Wall St. Rank reported a position in Serina Therapeutics (SER) for Q4 2019, worth a combined $11.9M — down 9.3% from $13.1M a quarter earlier.

Sellers outnumbered buyers: 11 funds closed out of SER and 6 opened new positions — a net loss of 5 holders — while 11 trimmed existing stakes and 15 added.

The largest buyer was JP Morgan Chase, adding an estimated $32.2K. The largest seller was Defender Capital, cutting an estimated $103K.

  • 51 institutional investors held Serina Therapeutics (SER) as of Q4 2019, down from 56 in Q3 2019.
  • Funds reported $11.9M of Serina Therapeutics stock for Q4 2019, down 9.3% quarter-over-quarter.
  • 6 funds opened new Serina Therapeutics positions in Q4 2019 and 11 closed out, a net change of -5 holders.
  • The largest Serina Therapeutics buyer in Q4 2019 was JP Morgan Chase, an estimated $32.2K added.
  • The largest Serina Therapeutics seller in Q4 2019 was Defender Capital, an estimated $103K sold.

Based on aggregated 13F filings for Q4 2019.